Novel Insights into the Etiology, Mechanisms, and Treatment of Cancer Cachexia

Articles

ORIGINAL RESEARCH

Published on 24 Jun 2022

Primary Tumor Fluorine‐18 Fluorodeoxydglucose (18F‐FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival

ORIGINAL RESEARCH

Published on 15 Jun 2022

Cytokine-Mediated STAT3 Transcription Supports ATGL/CGI-58-Dependent Adipocyte Lipolysis in Cancer Cachexia

ORIGINAL RESEARCH

Published on 03 Jun 2022

Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer

MINI REVIEW

Published on 12 May 2022

Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia

ORIGINAL RESEARCH

Published on 14 Feb 2022

Establishment and Validation of Pre-Therapy Cervical Vertebrae Muscle Quantification as a Prognostic Marker of Sarcopenia in Patients With Head and Neck Cancer

ORIGINAL RESEARCH

Published on 11 Nov 2021

Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study

Share on

Frontiers in Oncology

Submit your idea

Articles

Primary Tumor Fluorine‐18 Fluorodeoxydglucose (18F‐FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival

Cytokine-Mediated STAT3 Transcription Supports ATGL/CGI-58-Dependent Adipocyte Lipolysis in Cancer Cachexia

Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer

Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia

Establishment and Validation of Pre-Therapy Cervical Vertebrae Muscle Quantification as a Prognostic Marker of Sarcopenia in Patients With Head and Neck Cancer

Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study

Frontiers in Oncology